JNBA Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-41
Closed -$5K – 881
2025
Q4
$5K Hold
41
– – ﹤0.01% 574
2025
Q3
$4.11K Hold
41
– – ﹤0.01% 570
2025
Q2
$3.4K Buy
+41
New +$3.27K ﹤0.01% 567
2021
Q4
– Sell
-302
Closed -$38K – 891
2021
Q3
$38K Hold
302
– – 0.01% 327
2021
Q2
$41K Hold
302
– – 0.01% 313
2021
Q1
$41K Hold
302
– – 0.01% 306
2020
Q4
$43K Hold
302
– – 0.01% 278
2020
Q3
$34K Hold
302
– – 0.01% 283
2020
Q2
$34K Hold
302
– – 0.01% 272
2020
Q1
$23K Hold
302
– – 0.01% 296
2019
Q4
$29K Hold
302
– – 0.01% 306
2019
Q3
$23K Hold
302
– – ﹤0.01% 320
2019
Q2
$26K Hold
302
– – 0.01% 313
2019
Q1
$27K Hold
302
– – 0.01% 295
2018
Q4
$22K Buy
+302
New +$24.3K 0.01% 288
2018
Q3
– Sell
-302
Closed -$29K – 724
2018
Q2
$29K Hold
302
– – 0.01% 280
2018
Q1
$26K Hold
302
– – 0.01% 287
2017
Q4
$26K Hold
302
– – 0.01% 287
2017
Q3
$26K Hold
302
– – 0.01% 278
2017
Q2
$23K Hold
302
– – 0.01% 279
2017
Q1
$21K Hold
302
– – 0.01% 289
2016
Q4
$18K Buy
+302
New +$18.6K ﹤0.01% 313
2016
Q3
– Sell
-302
Closed -$16K – 1677
2016
Q2
$16K Buy
+302
New +$16.5K ﹤0.01% 309

Other funds holding XBI

JNBA Financial Advisors's XBI Position: Q1 2026 in Review

JNBA Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 41 shares — an estimated $5K sold.

JNBA Financial Advisors first reported a position in XBI in Q2 2016 and held it in 23 quarters. The position peaked at $43K in Q4 2020. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • JNBA Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • JNBA Financial Advisors sold 41 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $5K.
  • JNBA Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 23 quarters.
  • JNBA Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $43K in Q4 2020.
  • 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.